Juanita Perez

[FATIMA Higuera @FATIMAHiguera8]

https://t.co/6nN0UOjV3H

[Ramon Bataller @rabataller]

New insights on assessing LIVER FIBROSIS with NON-INVASIVE TESTS, just released by @NEJM:

- Key techniques & thresholds.
- Practical algorithms & actionable steps.
https://t.co/KkPHLNaLh3

[HEPATOLOGY Journal @HEP_Journal]

Artículo de revisión

Tratamiento médico de la colangitis esclerosante primaria: qué hemos aprendido y hacia dónde nos dirigimos

Karlsen et al.
#LiverX
https://t.co/pHRMJqhChr

[Carl Kay, MD @CarlKayMD]

The infamous “Rule of 5” of non-invasive testing presented at #ACG2025

▪️LSM cutoffs: 5–10–15–20 kPa
▪️<10 kPa excludes; ≥15 kPa = cACLD
▪️≥20 kPa ± Plt <150k → CSPH risk
▪️Skip EGD if <20 kPa & Plt ≥150k
▪️Repeat q1y or q3–5 yrs if mild disease

🙏Nancy Reau

[HEPATOLOGY Journal @HEP_Journal]

#HEP_highlights: A new voice in diagnosing and predicting hepatic encephalopathy.

Automated speech analysis predicted MHE —comparable to animal naming. Adding age & MELD-Na improved accuracy (AUC 0.82). The HEAR-MHE model predicted overt HE risk.

https://t.co/CHVbYdKi6x

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

Hepatic hypoxia in donation after circulatory death: Physiology, clinical relevance, & future directions
https://t.co/3j2z3OQmVf

[Liver Transplantation Journal (LTxJournal) @LTxJournal]

Management of obesity in liver transplant candidates & recipients: Rethinking the false dichotomy between pharmacotherapy and surgical intervention
https://t.co/JlVDwSpPqY

[Ramon Bataller @rabataller]

People often ask me: do you recommend NON-ALCOHOLIC BEER to patients that continue to drink regular beer?

Although it can be a practical solution, it has two risks:
- It predicts returning to alcoholic beverages.
- This paper shows that its sugar content is metabolically bad.

[Salvatore Piano @salvatore_piano]

📣New data on cirrhosis recompensation in @JHepatology

✅Only 7% meets strict Baveno VII criteria
✅Expanded criteria capture ~38% with similar low mortality risk

Recompensation:
⬇️systemic inflammation🔥
👍 improved hemodynamic
⬆️improved survival

https://t.co/xPcE25dPcC

[Juanita Perez @escope35]

@makrina_la Es verdad, he tenido malísima experiencia con @MetLifeMx .
Para empezar darte de alta como proveedor en su plataforma es una odisea.
Sin duda no lo recomiendo a nadie de mis pacientes.

[Medical Info @Medicalinfo111]

Approach to liver decompensation

[Juanita Perez @escope35]

@Eirace @HuertaAline Gracias!!!

[Juanita Perez @escope35]

The traditional Mesoamerican diet, commonly called the “Dieta de la milpa” (Milpa Diet), is based on fresh and unprocessed local crops. It could represent a viable dietary alternative to mitigate the effects of MASLD. #MASLD #Milpadiet
Review article available at:
https://t.co/BtsWDBPsys

[Scott Isaacs @scottisaacsmd]

Diagnosis tools for MASLD in the management of obesity.
https://t.co/kn41fPS3uV

[AJG - The American Journal of Gastroenterology @AmJGastro]

NEW ACG Clinical Guideline:

Malnutrition and Nutritional Recommendations in Liver Disease
Singal & Wong, et al.

📕 https://t.co/YcTCM2C5TD

@singal_ashwani @Robert_J_Wong @JasmohanBajaj @MLongMD

[Dr. Muhammad Moor @MoarSahitoPTI]

All Hepatitis types in one slide. 📌

[Guilherme Grossi, MD, MSc, PhD @gui_cancado]

Imperdible! @alehlatam @sebas_marciano @jturnesv

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

Do we need to treat cirrhotic PVT, and how? – #EASL2025
🗣️ @jcgarciapagan
📍 LT candidate → anticoagulate if >25%
🚫 No LT → consider if >50%
🔍 Anticoagulation may help beyond recanalization
🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH

[Graciela Castro Narro @GCastro_NarroMD]

Young Hepatologist #EASLCongress 2025 @issacvargas Sharig opportunities and challenges of hepatology training in México @alehlatam @incmnszmx Congratulations